The present invention relates to compounds of the formula (I):
and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
The present invention relates to compounds of the formula (I):
and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
2-PYRIDINE CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL MODULATORS
申请人:Pfizer Limited
公开号:EP2183241A2
公开(公告)日:2010-05-12
US8134007B2
申请人:——
公开号:US8134007B2
公开(公告)日:2012-03-13
[EN] PYRIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE LA PYRIDINE
申请人:PFIZER LTD
公开号:WO2008135826A2
公开(公告)日:2008-11-13
[EN] The present invention relates to compounds of the formula (I): (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain. [FR] La présente invention concerne des composés de formule (I) : (I) et des sels et solvates pharmaceutiquement acceptables de ceux-ci, des procédés pour la préparation des intermédiaires utilisés dans la préparation de ces composés et des compositions contenant ces composés et les utilisation de ces composés pour le traitement de la douleur.